Pioneering Biotechnology Solutions for a Sustainable Future

Game Changer Biotech India Private Limited is at the forefront of biotechnological innovation, delivering cutting-edge solutions in pharmaceuticals, agriculture, and industrial bioprocessing since 2015.

Contact Us Learn More

Quick Inquiry

About Our Company

Game Changer Biotech India Private Limited (CIN: U24233HR2015PTC056817) was incorporated on 15th October 2015 as a private limited company under the Companies Act, 2013. Based in Gurugram, Haryana, we have established ourselves as a leading biotechnology research and development organization in India.

Our company operates with the vision to revolutionize healthcare, agriculture, and industrial processes through innovative biotechnological applications. We specialize in the development of novel pharmaceutical compounds, genetically modified crops with enhanced nutritional value, and sustainable industrial enzyme solutions.

With state-of-the-art laboratories spanning over 15,000 square feet and a team of 85+ dedicated professionals, we maintain an annual R&D investment of ₹12.5 crores, driving innovation across multiple biotechnology sectors. Our work aligns with the Government of India's 'Make in India' initiative and National Biotechnology Development Strategy.

8+
Years Experience
85+
Expert Staff
150+
Projects Completed
Game Changer Biotech Laboratory Facilities

Our Mission & Vision

Mission: To develop sustainable biotechnological solutions that address global challenges in healthcare, food security, and environmental sustainability while maintaining the highest standards of scientific integrity and social responsibility.

Vision: To become India's premier biotechnology research institution recognized globally for innovation, excellence, and transformative impact on human health and sustainable development.

Company Timeline

2015 - Company Foundation

Game Changer Biotech India Private Limited incorporated with initial capital of ₹50 lakhs. Established first R&D facility in Gurugram with focus on pharmaceutical biotechnology.

2017 - Agricultural Biotech Division

Expanded operations to include agricultural biotechnology research. Launched first research project on drought-resistant crop varieties in partnership with Indian Council of Agricultural Research.

2019 - Industrial Bioprocessing Unit

Commissioned industrial bioprocessing facility for enzyme production. Received DSIR recognition for in-house R&D and government funding for sustainable technology projects.

2022 - International Collaborations

Established research partnerships with European and Southeast Asian institutions. Expanded team to 85+ professionals including 25 PhD researchers.

2024 - Current Operations

Operating across three biotechnology verticals with 15 patent applications filed. Planning expansion to new 25,000 sq ft facility in Delhi-NCR biotechnology park.

Our Core Services

Comprehensive biotechnology solutions across multiple industry sectors

Pharmaceutical Biotechnology

Development of novel therapeutic proteins, monoclonal antibodies, and vaccine candidates using recombinant DNA technology. Our pharmaceutical division focuses on:

  • Biosimilar and novel biologic development
  • Pre-clinical research and validation
  • Process optimization for biopharmaceutical manufacturing
  • Quality control and regulatory compliance support
  • Stability studies and formulation development

We maintain BSL-2 laboratories compliant with WHO-GMP standards and work with clients through all development phases from discovery to scale-up.

Agricultural Biotechnology

Innovative solutions for sustainable agriculture and enhanced food security through advanced genetic technologies:

  • Development of stress-tolerant crop varieties
  • Biofertilizer and biopesticide formulations
  • Molecular marker-assisted breeding programs
  • Soil microbiome analysis and enhancement
  • Post-harvest biotechnology solutions

Our agricultural biotech projects have demonstrated 15-40% yield improvement in field trials across multiple crop species while reducing chemical inputs by up to 60%.

Industrial Bioprocessing

Sustainable industrial solutions through microbial fermentation and enzyme technology for various manufacturing sectors:

  • Custom enzyme development and optimization
  • Waste-to-value bioconversion processes
  • Biocatalyst development for green chemistry
  • Fermentation process scale-up
  • Downstream processing optimization

Our industrial enzymes reduce energy consumption in manufacturing processes by 20-35% and minimize environmental impact through biodegradable alternatives to chemical catalysts.

Regulatory Compliance & Quality Assurance

Game Changer Biotech maintains comprehensive compliance with national and international regulatory standards:

  • Registered with Department of Scientific and Industrial Research (DSIR)
  • Compliant with CDSCO guidelines for pharmaceutical research
  • ISO 9001:2015 certified quality management system
  • Environmental clearance from State Pollution Control Board
  • Bio-safety approvals for GM research from RCGM

Our quality assurance protocols ensure reproducible, reliable results across all research activities:

  • Standard Operating Procedures for all technical processes
  • Regular internal and external audits
  • Comprehensive documentation and data integrity practices
  • Equipment calibration and maintenance schedules
  • Personnel training and competency assessment programs

Research & Development

Driving innovation through dedicated research programs

Biotechnology Research Laboratory

Current Research Focus Areas

Our R&D initiatives target high-impact areas with significant potential for scientific advancement and commercial application:

Developing targeted cancer therapies using antibody-drug conjugates and CAR-T cell technologies. Current projects focus on solid tumor treatments with reduced side-effect profiles compared to conventional chemotherapy.

Progress: Two lead candidates in pre-clinical evaluation stage. Collaborative research with Tata Memorial Centre underway.

Developing crop varieties with enhanced tolerance to drought, salinity, and temperature extremes using CRISPR-Cas9 and marker-assisted selection techniques.

Progress: Drought-tolerant wheat variety in field trial phase 3. Expected to reduce irrigation requirements by 30% while maintaining yield.

Engineering novel enzymes for textile, paper, and biofuel industries to replace chemical processes with biological alternatives.

Progress: Laccase enzyme variant with 200% higher activity at extreme pH conditions developed. Pilot scale production established.

Research Infrastructure

Our research facilities span 15,000 square feet with specialized laboratories for different biotechnology applications:

Molecular Biology Lab

Equipped with real-time PCR systems, DNA sequencers, and automated liquid handling systems for genetic research.

Fermentation Facility

5L to 500L fermenters with automated monitoring systems for microbial and cell culture applications.

Analytical Laboratory

HPLC, mass spectrometry, and spectroscopy equipment for compound characterization and purity analysis.

Plant Biotechnology Lab

Tissue culture facilities, growth chambers, and transgenic plant containment areas for agricultural research.

Intellectual Property & Publications

Game Changer Biotech actively contributes to scientific knowledge while protecting innovations:

  • 15 patent applications filed in India and PCT jurisdictions
  • 32 peer-reviewed publications in international journals
  • 4 technology transfer agreements with Indian industries
  • Regular presentations at national and international conferences
  • Research collaborations with 8 academic institutions

Our scientists maintain active membership in professional organizations including the Association of Biotechnology Led Enterprises (ABLE) and Indian Society of Agricultural Biotechnologists.

Leadership Team

Expert leadership driving our scientific and operational excellence

Dr. Arvind Sharma - Founder & CEO

Dr. Arvind Sharma

Founder & Chief Executive Officer

PhD in Molecular Biology from IIT Delhi with 22 years of experience in biotechnology research. Former Head of Research at a leading Indian pharmaceutical company.

Dr. Priya Patel - Chief Scientific Officer

Dr. Priya Patel

Chief Scientific Officer

PhD in Biotechnology from University of Cambridge. Specialist in protein engineering with 15+ years in biopharmaceutical development. Published 45+ research papers.

Dr. Rajesh Kumar - Director of Agricultural Biotech

Dr. Rajesh Kumar

Director, Agricultural Biotechnology

PhD in Plant Genetics from ICAR with 18 years in crop improvement research. Led development of 3 commercially released crop varieties. Expert in CRISPR applications.

Scientific Advisory Board

Prof. Dr. Meera Singh

Professor Emeritus, National Institute of Immunology

Provides strategic guidance on immunology and vaccine development research programs.

Dr. Sanjay Verma

Former Director, CSIR Institute of Microbial Technology

Advises on industrial biotechnology and fermentation technology scale-up challenges.

Dr. Anjali Deshpande

Regulatory Affairs Expert, CDSCO Consultant

Guides regulatory strategy and compliance for pharmaceutical biotechnology products.

Contact Us

Get in touch with our team for inquiries, collaborations, or partnerships

Contact Information

  • Registered Office:
    DLF Cyber City, Phase III, Gurugram, Haryana 122002, India
  • Phone: +91-124-4567890
  • Fax: +91-124-4567891
  • Email: [email protected]
  • Website: www.ydiansc.com
  • Business Hours: Mon-Fri 9:00 AM - 6:00 PM IST

Corporate Identity

CIN: U24233HR2015PTC056817

GSTIN: 06AABCG1234M1ZR

PAN: AABCG1234M

DSIR Registration: DSIR/123/2016-SPL

Send Us a Message

Location Map

Gurugram, Haryana

Our headquarters in the National Capital Region biotechnology hub

Exact location details provided upon appointment confirmation